Catalog Number BXA052902E |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Thrombosis/Thrombus (4440)
|
Event Date 08/06/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
As the device remains implanted, no further investigation can be performed.No images are available for evaluation.The physician had expressed concern that the patient's unauthorized discontinuation of anti-platelet therapy may have contributed to the stenosis inside the gore® viabahn® vbx balloon expandable endoprosthesis.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Event Description
|
It was reported to gore that the patient underwent endovascular treatment with a gore® viabahn® vbx balloon expandable endoprosthesis because of a pseudoaneurysm of the renal artery on (b)(6) 2021.Reportedly, there were no complications in the procedure and the patient was initially well after the operation.It was stated, that sometime in mid-july the patient decided to stop taking his anti-platelet medicine of his own accord.The physician then ordered imaging to check the patency of the stent.The images demonstrated that the patient suffered a mild stenosis in the endoprosthesis in his renal artery.It was reported that the surgeon believes that the stenosis is closely associated with the discontinuation of the anti-platelet medication.On (b)(6) 2021, the stenosis was treated with a second gore® viabahn® vbx balloon expandable endoprosthesis during an endovascular reintervention.After this renal function was restored.
|
|
Manufacturer Narrative
|
Phr: a review of the manufacturing records indicated the lot met all pre-release specifications.A review of the sterilization records indicated the lot met all pre-release sterilization specifications.A review of the heparin coating records indicated the lot met all pre-release sterilization specifications.
|
|
Search Alerts/Recalls
|